Balchem Q2 Earnings: Record Sales and a Broad-Based Beat Across All Segments
BCPC sits 17% above its 52-week low of $139.17.
Summary
Balchem posted record Q2 2026 results, with sales of $284M (+11% YoY) and adjusted EPS of $1.49, beating consensus. All three segments grew, and aggressive share buybacks continued.
Key Events · Earnings and Guidance · BCPC
-
Record Q2 Sales and Earnings
New quarterly records were set as net sales reached $284.0M (+11.2% YoY) and GAAP net earnings climbed to $44.6M (+16.6% YoY). Adjusted EBITDA also hit a high of $77.9M (+12.6% YoY).
-
Broad-Based Segment Growth
All three segments contributed to the top line: Human Nutrition & Health rose 10.0% to $176.9M, Animal Nutrition & Health jumped 15.0% to $64.5M, and Specialty Products grew 8.9% to $40.5M.
-
Earnings Beat Consensus
Adjusted EPS of $1.49 surpassed the prior-year quarter's $1.27 and exceeded the Reuters-reported consensus of $268.5M in sales.
-
Aggressive Share Repurchases
Reflecting a balanced capital allocation strategy, $29M of common stock was repurchased in Q2, bringing the trailing twelve-month total to $114M.
Analysis · BCPC · Industrial Applications And Services
A clean beat in Q2 2026 underscores Balchem's momentum, with sales surging 11% to $284M against a $268.5M consensus and adjusted EPS of $1.49 topping estimates. Growth was broad-based—all three segments expanded, led by Animal Nutrition & Health at +15%. The quarter also saw $29M in stock repurchases, bringing the trailing twelve-month total to $114M, while the recently upsized $650M credit facility was reiterated. These results build on the strength noted last quarter and support the premium valuation.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 29.5% of the 1626 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BCPC was trading at $163.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.2B. The 52-week trading range was $139.17 to $183.90. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.